Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00POF
|
|||
| Former ID |
DNC012862
|
|||
| Drug Name |
6-Styryl-naphthalene-2-carboxamidine
|
|||
| Synonyms |
CHEMBL185345; 6-Styryl-naphthalene-2-carboxamidine; ZINC28365935
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H16N2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C=CC2=CC3=C(C=C2)C=C(C=C3)C(=N)N
|
|||
| InChI |
1S/C19H16N2/c20-19(21)18-11-10-16-12-15(8-9-17(16)13-18)7-6-14-4-2-1-3-5-14/h1-13H,(H3,20,21)/b7-6+
|
|||
| InChIKey |
YRAFBVUQILDIDH-VOTSOKGWSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cationic trypsinogen (PRSS1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Pancreatic secretion | ||||
| Protein digestion and absorption | ||||
| Influenza A | ||||
| Reactome | Activation of Matrix Metalloproteinases | |||
| Cobalamin (Cbl, vitamin B12) transport and metabolism | ||||
| WikiPathways | Activation of Matrix Metalloproteinases | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties. Bioorg Med Chem Lett. 2005 Jan 3;15(1):93-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.